NIH Guidelines: Honoring the Past, Charting the Future

July 18, 2017 - 8:30am to July 19, 2017 - 1:00pm
National Institutes of Health
5635 Fishers Lane
Bethesda, MD 20892

In honor of the recent 40th anniversary of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) as well as the emergence of new technologies in the life sciences, it is an opportune time to examine the current biosafety oversight framework, and discuss the future direction of biosafety oversight. In the decades since scientists gathered at Asilomar, there has been considerable evolution in molecular biology, our understanding of risk and safety, and biosafety oversight. While recombinant DNA has become ubiquitous, new emerging technologies – ranging from new genome editing tools to novel RNA applications – are presenting interesting challenges to our current biosafety framework.

With this in mind, the NIH Office of Science Policy will be hosting an upcoming workshop that will ask, if the Asilomar Conference were held today, what would the NIH Guidelines look like? Where would they fit within the current policy and regulatory landscape? What would be the role of the Recombinant DNA Advisory Committee (RAC)?

This workshop will be held on July 18 -19, 2017, in Rockville, MD.  For additional details and to register please visit the workshop website.

Questions about the workshop may be sent to